Stay updated with breaking news from File Acceptance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Formycon AG / Key word(s): Regulatory AdmissionFormycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara® (ustekinumab), by the U.S. Food and Drug Administration 30.11.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press R...
EQS-News: Formycon AG / Key word: Regulatory Admission/Miscellaneous Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 , by the U.S....
EQS-News: Formycon AG / Key word(s): Regulatory Admission/MiscellaneousFormycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA) 29.08.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press...
Investegate announcements from Formycon AG, Formycon and Bioeq announce File Acceptance for FYB201, a biosimilar candidate to Lucentis(R) (ranibizumab) by the U.S. Food and Drug Administration (FDA)